Copyright Reports & Markets. All rights reserved.

Global Cardiac Biomarkers Testing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cardiac Biomarkers Testing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Myocardial Muscle Creatine Kinase (CK-MB)
      • 1.4.3 Troponins (T and I)
      • 1.4.4 Myoglobin
      • 1.4.5 Brain Natriuretic Peptide (BNPs) or NT-proBNP
      • 1.4.6 Ischemia-modified Albumin (IMA)
      • 1.4.7 Others
    • 1.5 Market by Application
      • 1.5.1 Global Cardiac Biomarkers Testing Market Share by Application (2019-2025)
      • 1.5.2 Myocardial Infarction
      • 1.5.3 Congestive Heart Failure
      • 1.5.4 Acute Coronary Syndrome
      • 1.5.5 Atherosclerosis
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cardiac Biomarkers Testing Market Size
    • 2.2 Cardiac Biomarkers Testing Growth Trends by Regions
      • 2.2.1 Cardiac Biomarkers Testing Market Size by Regions (2019-2025)
      • 2.2.2 Cardiac Biomarkers Testing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Cardiac Biomarkers Testing Market Size by by Players
      • 3.1.1 Global Cardiac Biomarkers Testing Revenue by by Players (2014-2019)
      • 3.1.2 Global Cardiac Biomarkers Testing Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Cardiac Biomarkers Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cardiac Biomarkers Testing Key Players Head office and Area Served
    • 3.3 Key Players Cardiac Biomarkers Testing Product/Solution/Service
    • 3.4 Date of Enter into Cardiac Biomarkers Testing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cardiac Biomarkers Testing Market Size by Type (2014-2019)
    • 4.2 Global Cardiac Biomarkers Testing Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Cardiac Biomarkers Testing Market Size (2014-2019)
    • 5.2 Cardiac Biomarkers Testing Key Players in North America
    • 5.3 North America Cardiac Biomarkers Testing Market Size by Type
    • 5.4 North America Cardiac Biomarkers Testing Market Size by Application

    6 Europe

    • 6.1 Europe Cardiac Biomarkers Testing Market Size (2014-2019)
    • 6.2 Cardiac Biomarkers Testing Key Players in Europe
    • 6.3 Europe Cardiac Biomarkers Testing Market Size by Type
    • 6.4 Europe Cardiac Biomarkers Testing Market Size by Application

    7 China

    • 7.1 China Cardiac Biomarkers Testing Market Size (2014-2019)
    • 7.2 Cardiac Biomarkers Testing Key Players in China
    • 7.3 China Cardiac Biomarkers Testing Market Size by Type
    • 7.4 China Cardiac Biomarkers Testing Market Size by Application

    8 Japan

    • 8.1 Japan Cardiac Biomarkers Testing Market Size (2014-2019)
    • 8.2 Cardiac Biomarkers Testing Key Players in Japan
    • 8.3 Japan Cardiac Biomarkers Testing Market Size by Type
    • 8.4 Japan Cardiac Biomarkers Testing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cardiac Biomarkers Testing Market Size (2014-2019)
    • 9.2 Cardiac Biomarkers Testing Key Players in Southeast Asia
    • 9.3 Southeast Asia Cardiac Biomarkers Testing Market Size by Type
    • 9.4 Southeast Asia Cardiac Biomarkers Testing Market Size by Application

    10 India

    • 10.1 India Cardiac Biomarkers Testing Market Size (2014-2019)
    • 10.2 Cardiac Biomarkers Testing Key Players in India
    • 10.3 India Cardiac Biomarkers Testing Market Size by Type
    • 10.4 India Cardiac Biomarkers Testing Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cardiac Biomarkers Testing Market Size (2014-2019)
    • 11.2 Cardiac Biomarkers Testing Key Players in Central & South America
    • 11.3 Central & South America Cardiac Biomarkers Testing Market Size by Type
    • 11.4 Central & South America Cardiac Biomarkers Testing Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott Laboratories
      • 12.1.1 Abbott Laboratories Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cardiac Biomarkers Testing Introduction
      • 12.1.4 Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2014-2019))
      • 12.1.5 Abbott Laboratories Recent Development
    • 12.2 Becton, Dickinson and Company
      • 12.2.1 Becton, Dickinson and Company Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cardiac Biomarkers Testing Introduction
      • 12.2.4 Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2014-2019)
      • 12.2.5 Becton, Dickinson and Company Recent Development
    • 12.3 BioMerieux
      • 12.3.1 BioMerieux Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cardiac Biomarkers Testing Introduction
      • 12.3.4 BioMerieux Revenue in Cardiac Biomarkers Testing Business (2014-2019)
      • 12.3.5 BioMerieux Recent Development
    • 12.4 Bio-Rad Laboratories, Inc.
      • 12.4.1 Bio-Rad Laboratories, Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cardiac Biomarkers Testing Introduction
      • 12.4.4 Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2014-2019)
      • 12.4.5 Bio-Rad Laboratories, Inc. Recent Development
    • 12.5 Danaher Corporation
      • 12.5.1 Danaher Corporation Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cardiac Biomarkers Testing Introduction
      • 12.5.4 Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2014-2019)
      • 12.5.5 Danaher Corporation Recent Development
    • 12.6 F. HOFFMANN-LA ROCHE LTD.
      • 12.6.1 F. HOFFMANN-LA ROCHE LTD. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cardiac Biomarkers Testing Introduction
      • 12.6.4 F. HOFFMANN-LA ROCHE LTD. Revenue in Cardiac Biomarkers Testing Business (2014-2019)
      • 12.6.5 F. HOFFMANN-LA ROCHE LTD. Recent Development
    • 12.7 Siemens AG
      • 12.7.1 Siemens AG Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Cardiac Biomarkers Testing Introduction
      • 12.7.4 Siemens AG Revenue in Cardiac Biomarkers Testing Business (2014-2019)
      • 12.7.5 Siemens AG Recent Development
    • 12.8 Thermo Fisher Scientific, Inc.
      • 12.8.1 Thermo Fisher Scientific, Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Cardiac Biomarkers Testing Introduction
      • 12.8.4 Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2014-2019)
      • 12.8.5 Thermo Fisher Scientific, Inc. Recent Development
    • 12.9 PerkinElmer Inc.
      • 12.9.1 PerkinElmer Inc. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Cardiac Biomarkers Testing Introduction
      • 12.9.4 PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2014-2019)
      • 12.9.5 PerkinElmer Inc. Recent Development
    • 12.10 Tosoh Corporation
      • 12.10.1 Tosoh Corporation Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Cardiac Biomarkers Testing Introduction
      • 12.10.4 Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2014-2019)
      • 12.10.5 Tosoh Corporation Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
      Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
      In 2018, the global Cardiac Biomarkers Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Cardiac Biomarkers Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cardiac Biomarkers Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Abbott Laboratories
      Becton, Dickinson and Company
      BioMerieux
      Bio-Rad Laboratories, Inc.
      Danaher Corporation
      F. HOFFMANN-LA ROCHE LTD.
      Siemens AG
      Thermo Fisher Scientific, Inc.
      PerkinElmer Inc.
      Tosoh Corporation

      Market segment by Type, the product can be split into
      Myocardial Muscle Creatine Kinase (CK-MB)
      Troponins (T and I)
      Myoglobin
      Brain Natriuretic Peptide (BNPs) or NT-proBNP
      Ischemia-modified Albumin (IMA)
      Others

      Market segment by Application, split into
      Myocardial Infarction
      Congestive Heart Failure
      Acute Coronary Syndrome
      Atherosclerosis
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Cardiac Biomarkers Testing status, future forecast, growth opportunity, key market and key players.
      To present the Cardiac Biomarkers Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Cardiac Biomarkers Testing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now